VEGF165, Human (CHO-derived) Recombinant

• Description: Recombinant human vascular endothelial growth factor (VEGF) 165 expressed in CHO cells. Human VEGF exists in multiple molecular variants and are named based on the number of amino acids they contain. VEGF165 is the most common form of VEGF.
• UniProt: P15692-4
• Endotoxin: Endotoxin level was found to be < 0.1 ng/µg (1 EU/µg), using the LAL gel clot method.
• Purity: > 95%, as determined by SDSPAGE and HPLC.
• Reconstitution: Briefly centrifuge the vial, followed by reconstitution in distilled water to a concentration of
  0.1 mg/ml. This solution can then be further diluted into other buffers containing carrier protein (0.1% BSA) .
• Shipping Conditions: -80°C
• Storage Conditions: The lyophilized protein is stable for at least 2 years from date of receipt when stored at -20°C. Upon reconstitution, store in working aliquots at 2 - 8° C for up to one month, or at -20°C for up to six months, in the presence of a carrier protein. Avoid repeated freeze/thaw cycles.
• Calculated Molecular Weight: 19 kDa
• Formulation: Recombinant VEGF lyophilized from 0.2 μm filtered 20 mM PB solution, pH 7.0.